Jeffrey Eisele

APLS

Jeffrey Eisele serves as Chief Development Officer at Apellis Pharmaceuticals, Inc. (APLS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

17 trades

$1.66M

Net Position

Net Seller

$1.66M

Companies Traded

APLS

Active Period

Dec 2021 – Jan 2025

17 total trades

Most Recent

Sell APLS

Jan 29, 2025 · $8.2K

Jeffrey Eisele's Insider Trading at Apellis Pharmaceuticals, Inc. (APLS)

Buys

0 · $0.00

Sells

17 · $1.66M

Total Shares Bought

Total Shares Sold

28,123

APLS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jan 29, 2025	Sell	278	$29.52	$8.2K
Jan 22, 2025	Sell	1,291	$30.43	$39.3K
Jan 13, 2025	Sell	264	$28.70	$7.6K
Dec 23, 2024	Sell	63	$33.09	$2.1K
Jan 29, 2024	Sell	1,250	$65.22	$81.5K
Jan 23, 2024	Sell	7,378	$63.69	$469.9K
Jan 22, 2024	Sell	1,607	$65.00	$104.4K
Jan 17, 2024	Sell	5,207	$65.58	$341.5K
Jan 16, 2024	Sell	438	$66.81	$29.3K
Dec 26, 2023	Sell	303	$59.70	$18.1K
Feb 23, 2023	Sell	1,646	$68.76	$113.2K
Feb 21, 2023	Sell	825	$58.50	$48.3K
Jan 30, 2023	Sell	883	$52.76	$46.6K
Jan 23, 2023	Sell	4,479	$51.58	$231.0K
Jan 20, 2023	Sell	2,033	$52.05	$105.8K
Apr 25, 2022	Sell	89	$51.68	$4.6K
Dec 22, 2021	Sell	89	$47.82	$4.3K